Poland· PL-100049492
Omnipaque
A iohexol product containing iohexolum, registered in Poland by GE Healthcare A.S.. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Iohexol is registered in 17 of 19 countries.
Countries holding a registration under ATC V08AB02 (iohexol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Iohexol · ATC V08AB02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Iohexolum
- Manufacturer
- GE Healthcare A.S.
- Country
- Poland (PL)
- ATC code
- V08AB02
- ATC class
- Iohexol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
- gtin05909990286010
- gtin05909990286027
- gtin05909990286034
- gtin05909990286041
- gtin05909990286058
- gtin05909990286065
- gtin05909990286072
- gtin05909990286089
- gtin05909990286096
- gtin05909990669882
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
353 interactions on record for iohexol.
Graded by severity as the source publishes them — 286 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Iohexol · interactions on record
353 records
- 286 severe
- 54 moderate
- 13 info
Most severe, free to view
- MetoclopramideA03FA01severe
- ThiethylperazinA04AB03severe
- TriflupromazinA04AD06severe
- DronabinolA04AD10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Iohexol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- Japanイオヘキソール富士製薬工業
- United KingdomIohexol 647mg/ml (Iodine 300mg/ml) solution for injection 100ml bottlesFarmak Pharmaceuticals UK Ltd
- CzechiaOMNIPAQUEGE Healthcare AS, Oslo
- BelgiumOmnipaque 180 mg I/mlGE Healthcare
- United StatesIohexolAmneal Pharmaceuticals Private Limited
- SwedenIohexol ICG farma 300 mg I/ml Injektionsvätska, lösningUAB ICG farma
- IrelandOmnipaque 140 mg I/ml Solution for Injection (Glass)GE Healthcare AS
- NetherlandsIohexol ADOH 350 mg I/ml oplossing voor injectieADOH B.V.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Accupaque, Iovision
- Belgium · Omnipaque
- Bulgaria · Kopaq, Контамедиа Йох
- Cyprus · Omnipaque
- Czechia · Omnipaque
- Germany · Accupaque, Iovision
- Estonia · Iohexol Imax, Omnipaque
- Spain · Omnipaque
- Finland · Omnipaque
- France · Omnipaque
- United Kingdom (Northern Ireland) · Iohexol Farmak Pharmaceuticals Uk, Iohexol Ge Healthcare
- Greece · Omnipaque
- Croatia · Omnipaque
- Hungary · Iohexol Wogen, Omnipaque
- Ireland · Omnipaque
- Iceland · Omnipaque
- Italy · Omnipaque
- Lithuania · Iohexol Icg Farma, Iohexol Imax
- Luxembourg · Omnipaque
- Latvia · Iohexol Imax, Omnipaque
- Malta · Omnipaque
- Netherlands · Iohexol Adoh, Omnipaque
- Norway · Omnipaque
- Portugal · Iohexol Imax, Omnipaque
- Romania · Omnipaque
- Sweden · Iovision, Omnipaque
- Slovenia · Omnipaque
- Slovakia · Omnipaque
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/eea888d3-ac7e-4912-85ab-16e7c483cac5 GET /v1/drugs/eea888d3-ac7e-4912-85ab-16e7c483cac5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "518 mg/ml (240 mg jodu/ml)",
"packaging": "05909990286010 ¦ Rp ¦ Skasowane ¦ 7410\n1 fiol. 10 ml\n05909990286027 ¦ Rp ¦ 7411\n10 fiol. 10 ml\n05909990286034 ¦ Rp ¦ Skasowane ¦ 7412\n1 fiol. 20 ml\n05909990286041 ¦ Rp ¦ 7413\n6 fiol. 20 ml\n05909990286058 ¦ Rp ¦ 7414\n25 fiol. 20 ml\n05909990286065 ¦ Rp ¦ Skasowane ¦ 7415\n1 fiol. 50 ml\n05909990286072 ¦ Rp ¦ 7416\n10 butelek 50 ml\n05909990286089 ¦ Rp ¦ Skasowane ¦ 7417\n1 fiol. 200 ml\n05909990286096 ¦ Rp ¦ 7418\n6 butelek 200 ml\n05909990669882 ¦ Rp ¦ 46598\n10 butelek 50 ml",
"substance": "Iohexolum 518 mg/ml",
"common_name": "Iohexolum",
"pl_product_id": "100049492",
"pozwolenie_nr": "02860",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about iohexol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.